Moderna, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
MRNA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
325 Binney Street, Cambridge, MA

Insiders trading volume in the past year

Moderna, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stephane Bancel Chief Executive Officer, Director $1.81B -$2.34M -0.13% Jun 14, 2024
Noubar Afeyan Director $834M -$67.4M -7.48% Jul 31, 2024
Stephen Hoge President $69.4M -$17.9M -20.5% Dec 2, 2024
James M. Mock Chief Financial Officer $8.7M -$749K -7.93% Dec 5, 2024
Stephen Berenson Director $2.52M May 3, 2024
Arpa Garay Chief Commercial Officer $1.52M Dec 5, 2023
Juan Andres Chief Technical Operations and Quality Officer $1.33M Dec 28, 2022
Shannon Thyme Klinger Chief Legal Officer $1.01M -$1.41M -58.1% Dec 6, 2024
David W. Meline Chief Financial Officer $645K Aug 9, 2022
Paul Burton Chief Medical Officer $542K Nov 4, 2022
Elizabeth G. Nabel Director $350K May 3, 2024
Sandra Horning Director $111K May 6, 2024
Lori M. Henderson General Counsel and Secretary $93.6K May 27, 2021
David M. Rubenstein Director $82.3K Aug 5, 2024
Abbas Hussain Director $65.6K Oct 2, 2024
Robert Langer Director May 6, 2024
Jorge M. Gomez Officer May 9, 2022
Paul Sagan Director May 6, 2024
Francois Nader Director May 6, 2024
Elizabeth E. Tallett Director May 6, 2024
Tal Zvi Zaks Chief Medical Officer Jun 30, 2021

Recent Insider Transactions by Companies or Individuals for Moderna, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.